MHUA
Meihua International Medical Technologies Co., Ltd.
Medical - Instruments & Supplies
Market Cap$2M
5Y Perf.-99.1%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
MHUA vs MMSI
Revenue, margins, valuation, and 5-year total return — side by side.
MMSI
Merit Medical Systems, Inc.
Medical - Instruments & Supplies
Market Cap$3.72B
5Y Perf.+18.7%
MHUA vs MMSI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | MHUA | MMSI |
|---|---|---|
| Industry | Medical - Instruments & Supplies | Medical - Instruments & Supplies |
| Market Cap | $2M | $3.72B |
| Revenue (TTM) | $184M | $1.54B |
| Net Income (TTM) | $19M | $139M |
| Gross Margin | 33.6% | 48.7% |
| Operating Margin | 12.6% | 12.2% |
| Forward P/E | 0.2x | 15.5x |
| Total Debt | $8M | $898M |
| Cash & Equiv. | $16M | $449M |
MHUA vs MMSI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
MHUA
MMSI
| Stock | Feb 22 | Apr 26 | Return |
|---|---|---|---|
| Meihua Internationa… (MHUA) | 100 | 0.9 | -99.1% |
| Merit Medical Syste… (MMSI) | 100 | 118.7 | +18.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MHUA vs MMSI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: MHUA and MMSI are tied at the top with 3 categories each — the right choice depends on your priorities. Merit Medical Systems, Inc. is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
MHUA
Meihua International Medical Technologies Co., Ltd.
The Defensive Pick
MHUA has the current edge in this matchup, primarily because of its strength in sleep-well-at-night.
- Lower volatility, beta 2.86, Low D/E 5.0%, current ratio 5.26x
- Lower P/E (0.2x vs 15.5x)
- 10.1% margin vs MMSI's 9.0%
Best for: sleep-well-at-night
MMSI
Merit Medical Systems, Inc.
The Income Pick
MMSI is the clearest fit if your priority is income & stability and growth exposure.
- beta 0.71
- Rev growth 11.7%, EPS growth 4.9%, 3Y rev CAGR 9.6%
- 214.6% 10Y total return vs MHUA's -99.4%
Best for: income & stability and growth exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | MMSI | 11.7% revenue growth vs MHUA's -0.2% |
| Value | MHUA | Lower P/E (0.2x vs 15.5x) |
| Quality / Margins | MHUA | 10.1% margin vs MMSI's 9.0% |
| Stability / Safety | MMSI | Beta 0.71 vs MHUA's 2.86 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | MMSI | -33.8% vs MHUA's -73.6% |
| Efficiency (ROA) | MHUA | 9.7% ROA vs MMSI's 5.2%, ROIC 7.4% vs 7.2% |
MHUA vs MMSI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2025
MHUA vs MMSI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLMMSILAGGINGMHUA
MHUAMeihua International …
2leads
MMSIMerit Medical Systems…
3leads
6 Total Categories
CATEGORYLEADERvs MHUAMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
MMSI4/6
Valuation MetricsMultiples, price ratios, and targets
MHUA5/5
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
MHUA8/9
Total Returns1Y, 3Y, 5Y total returns with dividends
MMSI5/6
Risk & VolatilityBeta, volatility, and downside exposure
MMSI2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
MMSI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MMSI is the larger business by revenue, generating $1.5B annually — 8.4x MHUA's $184M. Profitability is closely matched — net margins range from 10.1% (MHUA) to 9.0% (MMSI). On growth, MMSI holds the edge at +7.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | MHUAMeihua Internatio… | MMSIMerit Medical Sys… |
|---|---|---|
| RevenueTrailing 12 months | $184M | $1.5B |
| EBITDAEarnings before interest/tax | $24M | $290M |
| Net IncomeAfter-tax profit | $19M | $139M |
| Free Cash FlowCash after capex | $12M | $274M |
| Gross MarginGross profit ÷ Revenue | +33.6% | +48.7% |
| Operating MarginEBIT ÷ Revenue | +12.6% | +12.2% |
| Net MarginNet income ÷ Revenue | +10.1% | +9.0% |
| FCF MarginFCF ÷ Revenue | +6.6% | +17.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -16.2% | +7.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -35.8% | +38.8% |
MMSI leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
MHUA leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
At 0.2x trailing earnings, MHUA trades at a 99% valuation discount to MMSI's 29.3x P/E.
| Metric | MHUAMeihua Internatio… | MMSIMerit Medical Sys… |
|---|---|---|
| Market CapShares × price | $2M | $3.7B |
| Enterprise ValueMkt cap + debt − cash | -$6M | $4.2B |
| Trailing P/EPrice ÷ TTM EPS | 0.19x | 29.26x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 15.46x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | -0.40x | 13.06x |
| Price / SalesMarket cap ÷ Revenue | 0.02x | 2.45x |
| Price / BookPrice ÷ Book value/share | 0.01x | 2.38x |
| Price / FCFMarket cap ÷ FCF | 0.14x | 17.24x |
MHUA leads this category, winning 5 of 5 comparable metrics.
Profitability & Efficiency
MHUA leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
MHUA delivers a 11.2% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $9 for MMSI. MHUA carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to MMSI's 0.57x. On the Piotroski fundamental quality scale (0–9), MMSI scores 6/9 vs MHUA's 4/9, reflecting solid financial health.
| Metric | MHUAMeihua Internatio… | MMSIMerit Medical Sys… |
|---|---|---|
| ROE (TTM)Return on equity | +11.2% | +8.9% |
| ROA (TTM)Return on assets | +9.7% | +5.2% |
| ROICReturn on invested capital | +7.4% | +7.2% |
| ROCEReturn on capital employed | +9.4% | +7.9% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.05x | 0.57x |
| Net DebtTotal debt minus cash | -$8M | $450M |
| Cash & Equiv.Liquid assets | $16M | $449M |
| Total DebtShort + long-term debt | $8M | $898M |
| Interest CoverageEBIT ÷ Interest expense | 31.87x | 10.74x |
MHUA leads this category, winning 8 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
MMSI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MMSI five years ago would be worth $9,644 today (with dividends reinvested), compared to $59 for MHUA. Over the past 12 months, MMSI leads with a -33.8% total return vs MHUA's -73.6%. The 3-year compound annual growth rate (CAGR) favors MMSI at -9.8% vs MHUA's -71.3% — a key indicator of consistent wealth creation.
| Metric | MHUAMeihua Internatio… | MMSIMerit Medical Sys… |
|---|---|---|
| YTD ReturnYear-to-date | +271.2% | -27.9% |
| 1-Year ReturnPast 12 months | -73.6% | -33.8% |
| 3-Year ReturnCumulative with dividends | -97.6% | -26.5% |
| 5-Year ReturnCumulative with dividends | -99.4% | -3.6% |
| 10-Year ReturnCumulative with dividends | -99.4% | +214.6% |
| CAGR (3Y)Annualised 3-year return | -71.3% | -9.8% |
MMSI leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
MMSI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
MMSI is the less volatile stock with a 0.71 beta — it tends to amplify market swings less than MHUA's 2.86 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MMSI currently trades 62.2% from its 52-week high vs MHUA's 11.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | MHUAMeihua Internatio… | MMSIMerit Medical Sys… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.86x | 0.71x |
| 52-Week HighHighest price in past year | $64.00 | $100.19 |
| 52-Week LowLowest price in past year | $2.05 | $59.74 |
| % of 52W HighCurrent price vs 52-week peak | +11.9% | +62.2% |
| RSI (14)Momentum oscillator 0–100 | 49.3 | 34.9 |
| Avg Volume (50D)Average daily shares traded | 1K | 769K |
MMSI leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | MHUAMeihua Internatio… | MMSIMerit Medical Sys… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $95.00 |
| # AnalystsCovering analysts | — | 13 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +9.6% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
MMSI leads in 3 of 6 categories (Income & Cash Flow, Total Returns). MHUA leads in 2 (Valuation Metrics, Profitability & Efficiency).
Best OverallMerit Medical Systems, Inc. (MMSI)Leads 3 of 6 categories
Loading custom metrics...
MHUA vs MMSI: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is MHUA or MMSI a better buy right now?
For growth investors, Merit Medical Systems, Inc.
(MMSI) is the stronger pick with 11. 7% revenue growth year-over-year, versus -0. 2% for Meihua International Medical Technologies Co. , Ltd. (MHUA). Meihua International Medical Technologies Co. , Ltd. (MHUA) offers the better valuation at 0. 2x trailing P/E, making it the more compelling value choice. Analysts rate Merit Medical Systems, Inc. (MMSI) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MHUA or MMSI?
On trailing P/E, Meihua International Medical Technologies Co.
, Ltd. (MHUA) is the cheapest at 0. 2x versus Merit Medical Systems, Inc. at 29. 3x.
03Which is the better long-term investment — MHUA or MMSI?
Over the past 5 years, Merit Medical Systems, Inc.
(MMSI) delivered a total return of -3. 6%, compared to -99. 4% for Meihua International Medical Technologies Co. , Ltd. (MHUA). Over 10 years, the gap is even starker: MMSI returned +214. 6% versus MHUA's -99. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MHUA or MMSI?
By beta (market sensitivity over 5 years), Merit Medical Systems, Inc.
(MMSI) is the lower-risk stock at 0. 71β versus Meihua International Medical Technologies Co. , Ltd. 's 2. 86β — meaning MHUA is approximately 302% more volatile than MMSI relative to the S&P 500. On balance sheet safety, Meihua International Medical Technologies Co. , Ltd. (MHUA) carries a lower debt/equity ratio of 5% versus 57% for Merit Medical Systems, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MHUA or MMSI?
By revenue growth (latest reported year), Merit Medical Systems, Inc.
(MMSI) is pulling ahead at 11. 7% versus -0. 2% for Meihua International Medical Technologies Co. , Ltd. (MHUA). On earnings-per-share growth, the picture is similar: Merit Medical Systems, Inc. grew EPS 4. 9% year-over-year, compared to -18. 4% for Meihua International Medical Technologies Co. , Ltd.. Over a 3-year CAGR, MMSI leads at 9. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MHUA or MMSI?
Meihua International Medical Technologies Co.
, Ltd. (MHUA) is the more profitable company, earning 11. 2% net margin versus 8. 5% for Merit Medical Systems, Inc. — meaning it keeps 11. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MHUA leads at 14. 8% versus 12. 2% for MMSI. At the gross margin level — before operating expenses — MMSI leads at 48. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — MHUA or MMSI?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is MHUA or MMSI better for a retirement portfolio?
For long-horizon retirement investors, Merit Medical Systems, Inc.
(MMSI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 71), +214. 6% 10Y return). Meihua International Medical Technologies Co. , Ltd. (MHUA) carries a higher beta of 2. 86 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MMSI: +214. 6%, MHUA: -99. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between MHUA and MMSI?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MHUA is a small-cap deep-value stock; MMSI is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(MHUA: -16.2% · MMSI: 7.8%)Net Margin>
%
(MHUA: 10.1% · MMSI: 9.0%)P/E Ratio<
x
(MHUA: 0.2x · MMSI: 29.3x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.